An evaluation of service expansion to include patients with heart failure with preserved ejection fraction

Journal article

Peplow, J. and Rees, S. (2024). An evaluation of service expansion to include patients with heart failure with preserved ejection fraction. British Journal of Cardiac Nursing. https://doi.org/10.12968/bjca.2023.0082

Publication dates
Authors	Peplow, J. and Rees, S.
Abstract	Background/Aims The Central London Community Healthcare Trust West Hertfordshire heart failure service expanded in 2020 to include patients with heart failure with preserved ejection fraction in addition to the patients with heart failure with reduced ejection fraction. The patient population was predicted to double, requiring staff and service adjustments; this warranted an evaluation to determine if care targets were maintained. This study aimed to evaluate the impact of service expansion on service referral rates, length of stay in the service and clinical workload. Methods A retrospective quantitative evaluation of the service data from October 2020 to April 2021 was undertaken to compare referral rates, length of stay in service and key workload metrics between patients with heart failure with reduced ejection fraction and those with heart failure with preserved ejection fraction. All referrals to the service with a new diagnosis of heart failure (confirmed by echocardiogram or magnetic resonance imaging) were considered for evaluation. Of 250 eligible referrals, 81 were selected for inclusion using a random sampling method. Results The participants with heart failure with preserved ejection fraction had a median length of stay in the service of 17 weeks. The participants with heart failure with reduced ejection fraction had a statistically significant longer stay of 35.57 weeks (P<0.001) compared to a pre-expansion length of stay of approximately 17 weeks. Workload was proportional between the two cohorts. Patients with heart failure with preserved ejection fraction were more likely to be reviewed in multidisciplinary teams or by the consultant community clinic. This group was less likely to attend clinic, where 96.4% of face-to-face reviews took place at home. Telephone reviews occurred at a similar frequency for both cohorts, comprising 50% of follow ups. The heart failure with reduced ejection fraction cohort required more alterations in medication and medication titration, generating additional follow ups. Conclusions The service expansion to include patients with heart failure with preserved ejection fraction has had a significant impact on workload, leading to a reduction in the quality of care for those with heart failure with reduced ejection fraction.
Year	2024
Journal	British Journal of Cardiac Nursing
Publisher	MA Healthcare
ISSN	2052-2207
Digital Object Identifier (DOI)	https://doi.org/10.12968/bjca.2023.0082
Print	15 Feb 2024
Publication process dates
Accepted	16 Dec 2023
Deposited	26 Mar 2024
Accepted author manuscript	An evaluation of service expansion to include patients with heart failure with preserved ejection fraction.docx License CC BY 4.0 File Access Level Open

Permalink -

https://openresearch.lsbu.ac.uk/item/96x1y

Download files

Accepted author manuscript

	An evaluation of service expansion to include patients with heart failure with preserved ejection fraction.docx
License: CC BY 4.0
File access level: Open

7
total views
1
total downloads
7
views this month
1
downloads this month

Export as

Related outputs

Oxybutynin

Rees, S. (2024). Oxybutynin. Journal of Prescribing Practice. 6 (2), pp. 50-51. https://doi.org/10.12968/jprp.2024.6.2.50

Vortioxetine

Rees, S. (2024). Vortioxetine. Journal of Prescribing Practice. 6 (1), pp. 6-7. https://doi.org/10.12968/jprp.2024.6.1.6

Drug Breakdown: Colchicine

Rees, Sharon (2023). Drug Breakdown: Colchicine. Journal of Prescribing Practice. 5 (12), pp. 490-491. https://doi.org/10.12968/jprp.2023.5.12.490

Domperidone

Rees, S. (2023). Domperidone. Journal of Prescribing Practice. 5 (11), pp. 446-447. https://doi.org/10.12968/jprp.2023.5.11.446

Drug Breakdown: Fentanyl

Rees, S. (2023). Drug Breakdown: Fentanyl. Journal of Prescribing Practice. 5 (10), pp. 404-404. https://doi.org/10.12968/jprp.2023.5.10.404

Drug breakdown: Bempedoic Acid

Rees, Sharon (2023). Drug breakdown: Bempedoic Acid. Journal of Prescribing Practice. 5 (9), pp. 360-361. https://doi.org/10.12968/jprp.2023.5.9.360

Drug Breakdown: Isotretinoin

Rees, S. (2023). Drug Breakdown: Isotretinoin. Journal of Prescribing Practice. 5 (8), pp. 316-317. https://doi.org/10.12968/jprp.2023.5.8.316

Drug Breakdown: Methylphenidate

Rees, S. (2023). Drug Breakdown: Methylphenidate. Journal of Prescribing Practice. 5 (7), pp. 272-273. https://doi.org/10.12968/jprp.2023.5.7.272

Drug Breakdown: Fosfomycin

Rees, S. (2023). Drug Breakdown: Fosfomycin. Journal of Prescribing Practice. 5 (6), pp. 228-229. https://doi.org/10.12968/jprp.2023.5.6.228

Drug Breakdown: Minoxidil

Rees, Sharon (2023). Drug Breakdown: Minoxidil. Journal of Prescribing Practice. 5 (5), pp. 184-185. https://doi.org/10.12968/jprp.2023.5.5.184

Book Review: Principles and Practice of Nurse Prescribing: Gould and Bain

Rees, S. (2023). Book Review: Principles and Practice of Nurse Prescribing: Gould and Bain. Journal of Prescribing Practice. 5 (4), pp. 172-172. https://doi.org/10.12968/jprp.2023.5.4.172

Drug Breakdown: Infliximab

Rees, S. (2023). Drug Breakdown: Infliximab. Journal of Prescribing Practice. 5 (4), pp. 140-140. https://doi.org/10.12968/jprp.2023.5.4.140

Drug Breakdown: Carbimazole

Rees, Sharon (2023). Drug Breakdown: Carbimazole. Journal of Prescribing Practice. 5 (3), pp. 96-97. https://doi.org/10.12968/jprp.2023.5.3.96

Drug Breakdown: Sitagliptin

Rees, Sharon (2023). Drug Breakdown: Sitagliptin. Journal of Prescribing Practice. 5 (2), pp. 52-53. https://doi.org/10.12968/jprp.2023.5.2.52

Drug Breakdown: Celecoxib

Rees, S. (2023). Drug Breakdown: Celecoxib. Journal of Prescribing Practice. 5 (1), pp. 8-8. https://doi.org/10.12968/jprp.2023.5.1.8

Drug Breakdown: Losartan

Rees, S. (2022). Drug Breakdown: Losartan. Journal of Prescribing Practice. 4 (12), pp. 518-518. https://doi.org/10.12968/jprp.2022.4.12.518

Daptomycin

Rees, Sharon (2022). Daptomycin. Journal of Prescribing Practice. 4 (11), pp. 474-474. https://doi.org/10.12968/jprp.2022.4.11.474

Drug Breakdown: sildenafil (Viagra)

Rees, S. (2022). Drug Breakdown: sildenafil (Viagra). Journal of Prescribing Practice. 4 (10), pp. 422-423. https://doi.org/10.12968/jprp.2022.4.10.422

PENTHROX

Rees, S. (2022). PENTHROX. Journal of Prescribing Practice. 4 (9), pp. 378-378. https://doi.org/10.12968/jprp.2022.4.9.378

Drug Breakdown: Omalizumab

Rees, S. (2022). Drug Breakdown: Omalizumab. Journal of Prescribing Practice. 4 (8), pp. 334-335. https://doi.org/10.12968/jprp.2022.4.8.334

Zopiclone

Rees, S. (2022). Zopiclone. Journal of Prescribing Practice. 4 (7), pp. 290-291. https://doi.org/10.12968/jprp.2022.4.7.290

INDAPAMIDE

Rees, S. (2022). INDAPAMIDE. Journal of Prescribing Practice. 4 (5), pp. 184-185. https://doi.org/10.12968/jprp.2022.4.5.184

What is the value of supplementary prescribing in the 2020s? A dietitian's perspective

Ruddock, N. and Rees, S. (2022). What is the value of supplementary prescribing in the 2020s? A dietitian's perspective. Journal of Prescribing Practice. 4 (5), pp. 194-199. https://doi.org/10.12968/jprp.2022.4.5.194

CAFFEINE

Rees, Sharon (2022). CAFFEINE. Journal of Prescribing Practice. 4 (4), pp. 140-141. https://doi.org/10.12968/jprp.2022.4.4.140

A warfarin-antibiotic drug-drug interaction

Feeney, S., Rees, S. and Modha, R.K. (2022). A warfarin-antibiotic drug-drug interaction. Journal of Prescribing Practice. 4 (4), pp. 156-159. https://doi.org/10.12968/jprp.2022.4.4.156

Quetiapine

Rees, S. (2022). Quetiapine. Journal of Prescribing Practice. 4 (3), pp. 96-96. https://doi.org/10.12968/jprp.2022.4.3.96

ALLOPURINOL

Rees, Sharon (2022). ALLOPURINOL. Journal of Prescribing Practice. 4 (2), pp. 51-51. https://doi.org/10.12968/jprp.2022.4.2.51

NYSTATIN

Rees, S. (2022). NYSTATIN. Journal of Prescribing Practice. 4 (1), pp. 8-8. https://doi.org/10.12968/jprp.2022.4.1.8

CLOPIDOGREL

Rees, Sharon (2021). CLOPIDOGREL. Journal of Prescribing Practice. 3 (12), pp. 474-475. https://doi.org/10.12968/jprp.2021.3.12.474

Sertraline

Rees, S. (2021). Sertraline. Journal of Prescribing Practice. 3 (11), pp. 436-436. https://doi.org/10.12968/jprp.2021.3.11.436

ALENDRONIC ACID

Rees, S. (2021). ALENDRONIC ACID. Journal of Prescribing Practice. 3 (10), pp. 386-386. https://doi.org/10.12968/jprp.2021.3.10.386

DEXAMETHASONE

Rees, S. (2021). DEXAMETHASONE. Journal of Prescribing Practice. 3 (9), pp. 342-342. https://doi.org/10.12968/jprp.2021.3.9.342

Memantine

Rees, S. (2021). Memantine. Journal of Prescribing Practice. 3 (8), pp. 298-298. https://doi.org/10.12968/jprp.2021.3.8.298

Ciprofloxacin

Rees, S. (2021). Ciprofloxacin. Journal of Prescribing Practice. 3 (7), pp. 254-255. https://doi.org/10.12968/jprp.2021.3.7.254

RIVAROXABAN

Rees, S. (2021). RIVAROXABAN. Journal of Prescribing Practice. 3 (6), pp. 210-212. https://doi.org/10.12968/jprp.2021.3.6.210

DAPAGLIFLOZIN

Rees, S. (2021). DAPAGLIFLOZIN. Journal of Prescribing Practice. 3 (5), pp. 166-166. https://doi.org/10.12968/jprp.2021.3.5.166

AZT / ABACAVIR

Rees, S. (2021). AZT / ABACAVIR. Journal of Prescribing Practice. 3 (4), pp. 132-132. https://doi.org/10.12968/jprp.2021.3.4.132

TAMOXIFEN

Rees, S. (2021). TAMOXIFEN. Journal of Prescribing Practice. 3 (3), pp. 96-96. https://doi.org/10.12968/jprp.2021.3.3.96

THEOPHYLLINE

Rees, S. (2021). THEOPHYLLINE. Journal of Prescribing Practice. 3 (2), pp. 52-52. https://doi.org/10.12968/jprp.2021.3.2.52

Drug Breakdown: CARBAMAZEPINE

Rees, Sharon (2021). Drug Breakdown: CARBAMAZEPINE. Journal of Prescribing Practice. 3 (1), pp. 8-9. https://doi.org/10.12968/jprp.2021.3.1.8

FLUCONAZOLE

Rees, S. (2020). FLUCONAZOLE. Journal of Prescribing Practice. 2 (12), pp. 657-657. https://doi.org/10.12968/jprp.2020.2.12.657

DABIGATRAN

Rees, S. (2020). DABIGATRAN. Journal of Prescribing Practice. 2 (11), pp. 564-565. https://doi.org/10.12968/jprp.2020.2.11.564

Drug Breakdown Nitrofurantoin

Rees, S. (2020). Drug Breakdown Nitrofurantoin. Journal of Prescribing Practice. 2 (10). https://doi.org/10.12968/jprp.2020.2.10.526

7 Days of Haloperidol

Rees, S. (2020). 7 Days of Haloperidol. Journal of Prescribing Practice. 2 (9). https://doi.org/10.12968/jprp.2020.2.9.476

Furosemide

Rees, S. (2020). Furosemide. Journal of Prescribing Practice. 2 (4), p. 165. https://doi.org/10.12968/jprp.2020.2.4.165

7 days of mercaptopurine

Rees, S. (2020). 7 days of mercaptopurine. Journal of Prescribing Practice. 2 (1). https://doi.org/10.12968/jprp.2020.2.1.6

7 days of doxycycline

Rees, S. (2020). 7 days of doxycycline. Journal of Prescribing Practice. 2 (5), p. 216. https://doi.org/10.12968/jprp.2020.2.5.216

7 days of hydroxychloroquine

Rees, S. (2020). 7 days of hydroxychloroquine . Journal of Prescribing Practice. 2 (6), p. 268. https://doi.org/10.12968/jprp.2020.2.6.268

CYCLIZINE

Rees, Sharon (2020). CYCLIZINE. Journal of Prescribing Practice. 2 (8), pp. 424-424. https://doi.org/10.12968/jprp.2020.2.8.424

Glyceryl Trinitrate

Rees, S. (2020). Glyceryl Trinitrate. Journal of Prescribing Practice. 2 (7), pp. 372-373. https://doi.org/10.12968/jprp.2020.2.7.372

Sprionolactone

Rees, S. (2019). Sprionolactone. Journal of Prescribing Practice. 1 (12), p. 579. https://doi.org/10.12968/jprp.2019.1.12.579

Higher degrees in nursing: traditional research PhD or professional doctorate?

Rees, S., Ousey, K., Koo, K., Ahmad, N. and Bowling, F. (2019). Higher degrees in nursing: traditional research PhD or professional doctorate? British Journal of Nursing. 28 (14), pp. 940-945. https://doi.org/10.12968/bjon.2019.28.14.940

Drug therapies to manage nausea and vomiting

Rees, SM (2018). Drug therapies to manage nausea and vomiting. Nurse Prescribing. 16 (1), pp. 37-44. https://doi.org/10.12968/npre.2018.16.1.37

Local Antibiotic Delivery Systems: Current and Future Applications for Diabetic Foot Infections.

Markakis, K, Faris, AR, Sharaf, H, Faris, B, Rees, SM and Bowling, FL (2018). Local Antibiotic Delivery Systems: Current and Future Applications for Diabetic Foot Infections. International Journal of Lower Extremity Wounds. 17 (1), pp. 14-21. https://doi.org/10.1177/1534734618757532